ロード中...
The characteristics and outcomes of critically Ill patients with COVID-19 who received systemic thrombolysis for presumed pulmonary embolism: an observational study
Coronavirus disease 2019 (COVID-19) is associated with abnormal hemostasis, autopsy evidence of systemic microthrombosis, and a high prevalence of venous thromboembolic disease. Tissue plasminogen activator (tPA) has been used in patients with critically ill COVID-19 with high clinical suspicion of...
保存先:
| 出版年: | J Thromb Thrombolysis |
|---|---|
| 主要な著者: | , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Springer US
2021
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8106515/ https://ncbi.nlm.nih.gov/pubmed/33966157 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11239-021-02477-5 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|